A detailed history of Janney Montgomery Scott LLC transactions in Kempharm, Inc stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 305,069 shares of KMPH stock, worth $1.51 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
305,069
Previous 432,824 29.52%
Holding current value
$1.51 Million
Previous $2.12 Million 0.19%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
N/A
-127,755 Reduced 29.52%
305,069 $2.12 Million
Q2 2024

Jul 25, 2024

SELL
N/A
-227,345 Reduced 34.44%
432,824 $2.12 Million
Q1 2024

May 01, 2024

SELL
N/A
-23,262 Reduced 3.4%
660,169 $3.83 Million
Q4 2023

Feb 07, 2024

BUY
N/A
9,062 Added 1.34%
683,431 $4.48 Million
Q3 2023

Nov 08, 2023

BUY
N/A
151,599 Added 29.0%
674,369 $3.25 Million
Q2 2023

Jul 26, 2023

SELL
$4.94 - $6.29 $29,565 - $37,645
-5,985 Reduced 1.13%
522,770 $2.67 Million
Q1 2023

Apr 28, 2023

BUY
$4.13 - $6.27 $143,414 - $217,725
34,725 Added 7.03%
528,755 $2.91 Million
Q4 2022

Feb 01, 2023

BUY
$4.12 - $5.62 $60,358 - $82,333
14,650 Added 3.06%
494,030 $2.27 Million
Q3 2022

Oct 25, 2022

BUY
$4.5 - $6.85 $720 - $1,096
160 Added 0.03%
479,380 $2.99 Million
Q2 2022

Aug 03, 2022

BUY
$4.02 - $5.21 $518,981 - $672,611
129,100 Added 36.87%
479,220 $2.17 Million
Q1 2022

May 04, 2022

BUY
$5.0 - $9.26 $321,025 - $594,538
64,205 Added 22.46%
350,120 $1.76 Million
Q4 2021

Jan 27, 2022

BUY
$7.6 - $10.26 $49,210 - $66,433
6,475 Added 2.32%
285,915 $2.49 Million
Q3 2021

Oct 29, 2021

BUY
$8.72 - $13.31 $181,158 - $276,515
20,775 Added 8.03%
279,440 $2.61 Million
Q2 2021

Jul 26, 2021

BUY
$8.52 - $15.47 $2.1 Million - $3.81 Million
246,365 Added 2002.97%
258,665 $3.32 Million
Q1 2021

Apr 27, 2021

BUY
$5.6 - $13.47 $68,880 - $165,681
12,300 New
12,300 $113,000

Others Institutions Holding KMPH

About KEMPHARM, INC


  • Ticker KMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,493,600
  • Market Cap $170M
  • Description
  • KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...
More about KMPH
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.